Anti‐IgLON5 Disease Responsive to Immunotherapy: A Case Report with an Abnormal MRI
Sign Up to like & getrecommendations! Published in 2018 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12679
Abstract: A 65-year-old man presented with a 3-month history of gait disturbance, generalized chorea, and painful intermittent cervical dystonia. He also reported sleep disruption, mood changes, and irritability. He had a medical history of hypertension and… read more here.
Keywords: responsive immunotherapy; iglon5 disease; disease responsive; disease ... See more keywords
A GalNAc-modified CaCO3 nano-immunomodulator for targeted and responsive immunotherapy against orthotopic liver cancer.
Sign Up to like & getrecommendations! Published in 2024 at "Chemical communications"
DOI: 10.1039/d4cc01207k
Abstract: A nano-immunomodulator modified with N-acetylgalactosamine (GalNAc) on calcium carbonate (CaCO3) was prepared for targeted and responsive immunotherapy. And the immunologic adjuvant (CpG ODNs) and doxorubicin (DOX) were released to synergistically improve immune response for treating… read more here.
Keywords: targeted responsive; responsive immunotherapy; liver cancer; nano immunomodulator ... See more keywords